Key result
In patients with acute coronary syndrome, higher total daily doses and cigarette smoking were the only 2 covariates found to increase the total clearance of bisoprolol.
Why the study?
Questions regarding pharmacokinetic variability of bisoprolol remain unanswered, and no published population pharmacokinetic analyses exist in routinely treated patients with acute coronary syndrome.
What covariates influence the population pharmacokinetics and clearance of bisoprolol in patients with acute coronary syndrome?
Observational (n=71)
What covariates influence the population pharmacokinetics and clearance of bisoprolol in patients with acute coronary syndrome?
Higher total daily doses and smoking may increase the total clearance of bisoprolol in patients with acute coronary syndrome, potentially due to autoinduction and CYP3A4 induction.
Answers are grounded in this paper and cite their sources.
Smoking and higher doses may increase bisoprolol clearance in ACS; hypothesis-generating for dosing adjustments pending validation.
To date, many questions about the extent and cause of pharmacokinetic (PK) variability of even the most widely studied and prescribed β1-adrenergic receptor blockers, such as metoprolol and bisoprolol, remain unanswered. Given that there are still no published population pharmacokinetic (PopPK) analyses of bisoprolol in routinely treated patients with acute coronary syndrome (ACS), the aim of this study was to determine its PK variability in 71 Serbian patients with ACS. PopPK analysis was conducted using a nonlinear mixed-effects model (NONMEM), version 7.3.0 (Icon Development Solutions). In each patient, the same formulation of bisoprolol was administered once or twice daily at a total daily dose of 0.625-7.5 mg. We separately assessed the effects of 31 covariates on the PKs of bisoprolol, and our results indicated that only 2 covariates could have possible influence on the variability of the clearance of bisoprolol: the mean daily dose of the drug and smoking habits of patients. These findings suggest that possible autoinduction of drug metabolism by higher total daily doses and induction of cytochrome P450 isoform 3A4 (CYP3A4) by cigarette smoke in liver could be the potential causes of increased total clearance of bisoprolol in patients with ACS.
No takes yet. Share an insight, caveat, or question.
Momčilović et al. (2018) conducted an observational in Acute Coronary Syndrome (n=71). Bisoprolol was evaluated on Pharmacokinetic variability (clearance of bisoprolol). In patients with acute coronary syndrome, higher total daily doses and cigarette smoking were the only 2 covariates found to increase the total clearance of bisoprolol.
Synapse has enriched 10 related papers. Consider them for comparative context: